Close Menu

The UK's Guardian reports that "the European Patent Office has refused a patent covering the use of human embryonic stem cells on the grounds that it would be contrary to 'public order or morality.'" Referring to it as a "landmark ruling," the article goes on to say that if the patent had been granted, observers feared it would thwart companies engaged in developing hESC-based technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.